Nantahala Capital Management’s Strata Skin Sciences SSKN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-403,917
| Closed | -$509K | – | 175 |
|
|
2025
Q4 | $509K | Hold |
403,917
| – | – | 0.02% | 145 |
|
|
2025
Q3 | $832K | Hold |
403,917
| – | – | 0.03% | 144 |
|
|
2025
Q2 | $925K | Hold |
403,917
| – | – | 0.04% | 137 |
|
|
2025
Q1 | $1.07M | Hold |
403,917
| – | – | 0.04% | 121 |
|
|
2024
Q4 | $1.18M | Hold |
403,917
| – | – | 0.05% | 120 |
|
|
2024
Q3 | $1.11M | Buy |
403,917
+100,000
| +33% | +$312K | 0.06% | 111 |
|
|
2024
Q2 | $933K | Sell |
303,917
-5,065
| -2% | -$20.5K | 0.05% | 105 |
|
|
2024
Q1 | $1.17M | Sell |
308,982
-3,831
| -1% | -$20K | 0.07% | 102 |
|
|
2023
Q4 | $1.72M | Sell |
312,813
-13,682
| -4% | -$71.1K | 0.1% | 92 |
|
|
2023
Q3 | $1.94M | Sell |
326,495
-112,874
| -26% | -$867K | 0.17% | 89 |
|
|
2023
Q2 | $4.17M | Hold |
439,369
| – | – | 0.4% | 55 |
|
|
2023
Q1 | $4.65M | Hold |
439,369
| – | – | 0.36% | 51 |
|
|
2022
Q4 | $3.47M | Hold |
439,369
| – | – | 0.23% | 61 |
|
|
2022
Q3 | $3.83M | Sell |
439,369
-18,212
| -4% | -$185K | 0.25% | 57 |
|
|
2022
Q2 | $4.4M | Hold |
457,581
| – | – | 0.22% | 65 |
|
|
2022
Q1 | $6.73M | Hold |
457,581
| – | – | 0.3% | 57 |
|
|
2021
Q4 | $6.7M | Hold |
457,581
| – | – | 0.24% | 71 |
|
|
2021
Q3 | $8.42M | Sell |
457,581
-810
| -0.2% | -$12.4K | 0.27% | 72 |
|
|
2021
Q2 | $7.15M | Hold |
458,391
| – | – | 0.2% | 84 |
|
|
2021
Q1 | $7.66M | Sell |
458,391
-10,000
| -2% | -$181K | 0.22% | 73 |
|
|
2020
Q4 | $7.03M | Sell |
468,391
-115
| -0% | -$1.66K | 0.22% | 82 |
|
|
2020
Q3 | $6.33M | Hold |
468,506
| – | – | 0.19% | 79 |
|
|
2020
Q2 | $5.39M | Buy |
468,506
+143,406
| +44% | +$1.7M | 0.16% | 81 |
|
|
2020
Q1 | $3.09M | Buy |
325,100
+40,000
| +14% | +$660K | 0.12% | 85 |
|
|
2019
Q4 | $6.06M | Hold |
285,100
| – | – | 0.19% | 61 |
|
|
2019
Q3 | $6.13M | Hold |
285,100
| – | – | 0.23% | 65 |
|
|
2019
Q2 | $7.1M | Buy |
285,100
+20,800
| +8% | +$519K | 0.22% | 62 |
|
|
2019
Q1 | $7.53M | Sell |
264,300
-12,500
| -5% | -$380K | 0.24% | 59 |
|
|
2018
Q4 | $7.2M | Buy |
276,800
+20,911
| +8% | +$598K | 0.22% | 65 |
|
|
2018
Q3 | $9.06M | Buy |
255,889
+48,031
| +23% | +$1.18M | 0.24% | 59 |
|
|
2018
Q2 | $4.26M | Buy |
+207,858
| New | +$3.39M | 0.17% | 72 |
|
Nantahala Capital Management's SSKN Position: Q1 2026 in Review
Nantahala Capital Management sold out of Strata Skin Sciences (SSKN) in Q1 2026, closing a stake of 403,917 shares — an estimated $509K sold.
Nantahala Capital Management first reported a position in SSKN in Q2 2018 and held it in 31 quarters. The position peaked at $9.06M in Q3 2018. 0 funds tracked by Wall St. Rank hold SSKN as of Q1 2026.
- Nantahala Capital Management reported no remaining Strata Skin Sciences position as of Q1 2026 after selling out during the quarter.
- Nantahala Capital Management sold 403,917 Strata Skin Sciences shares in Q1 2026, an estimated $509K.
- Nantahala Capital Management first reported a position in Strata Skin Sciences in Q2 2018 and held it in 31 quarters.
- Nantahala Capital Management's Strata Skin Sciences position peaked at $9.06M in Q3 2018.
- 0 funds tracked by Wall St. Rank held Strata Skin Sciences as of Q1 2026.
Based on Nantahala Capital Management's 13F filing for Q1 2026, filed 15 May 2026.